caa a22 4500 605490511 CHVBK 20210128100505.0 cr unu---uuuuu 210128e20151201xx s 000 0 eng 10.1007/s10147-015-0830-7 doi (NATIONALLICENCE)springer-10.1007/s10147-015-0830-7 Is there any effect of first-day usage of a totally implantable venous access device on complications? [Elektronische Daten] [Hasan Karanlik, Hatice Odabas, Ilknur Yildirim, Ilker Ozgur, Berkay Kilic, Fatma Sen, Sidika Kurul, Adnan Aydiner] Background: Our aim was to evaluate whether it is safe to use a totally implantable venous access device (TIVAD) on the day of implantation. Methods: We investigated data from 1315 cancer patients divided into two groups according to the time interval between TIVAD placement and the first use of the TIVAD to adminster chemotherapy: patients whose devices were used during the first 24h after placement were enrolled into group 1 and patients whose devices were first used more than 24h after device placement were enrolled into group 2. Results: Early complications were all related to device insertion and occurred before chemotherapy administration. Infection and venous thrombosis were the most frequent complications during the first 6months after TIVAD insertion in both groups. However, the frequency of late complications was statistically the same for the two groups. Conclusions: The early use of TIVADs appears safe. Usage of the catheter for chemotherapy administration during the first 24h after insertion has no effect on the rate of complications. Japan Society of Clinical Oncology, 2015 Catheter nationallicence First use nationallicence Totally implantable venous access device nationallicence Karanlik Hasan Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut Odabas Hatice Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut Yildirim Ilknur Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut Ozgur Ilker Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey aut Kilic Berkay Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey aut Sen Fatma Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut Kurul Sidika Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut Aydiner Adnan Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut International Journal of Clinical Oncology Springer Japan 20/6(2015-12-01), 1057-1062 1341-9625 20:6<1057 2015 20 10147 https://doi.org/10.1007/s10147-015-0830-7 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-015-0830-7 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Karanlik Hasan Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut NATIONALLICENCE 700 1- Odabas Hatice Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut NATIONALLICENCE 700 1- Yildirim Ilknur Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut NATIONALLICENCE 700 1- Ozgur Ilker Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey aut NATIONALLICENCE 700 1- Kilic Berkay Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey aut NATIONALLICENCE 700 1- Sen Fatma Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut NATIONALLICENCE 700 1- Kurul Sidika Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey aut NATIONALLICENCE 700 1- Aydiner Adnan Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/6(2015-12-01), 1057-1062 1341-9625 20:6<1057 2015 20 10147